Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Metastatic Breast Cancer | Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer

45:58
 
Share
 

Manage episode 435800545 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Featuring an interview with Prof Giuseppe Curigliano, including the following topics:

  • Counseling patients with newly diagnosed metastatic breast cancer (mBC); role of patient-reported outcomes and advocacy (0:00)
  • Individualized selection of up-front therapy for patients with HR-positive, HER2-negative mBC (6:02)
  • Selection and sequencing of treatment for patients with HR-positive, HER2-negative disease who experience progression on CDK4/6 inhibition (9:40)
  • Current and future role of HER2-targeted therapy for HER2-low and HER2-ultralow mBC (19:46)
  • Selection and sequencing of therapy for patients with metastatic triple-negative breast cancer (29:53)
  • Emerging innovative interventions for the treatment of mBC (37:17)

CME information and select publications

  continue reading

1426 episodes

Artwork
iconShare
 
Manage episode 435800545 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Featuring an interview with Prof Giuseppe Curigliano, including the following topics:

  • Counseling patients with newly diagnosed metastatic breast cancer (mBC); role of patient-reported outcomes and advocacy (0:00)
  • Individualized selection of up-front therapy for patients with HR-positive, HER2-negative mBC (6:02)
  • Selection and sequencing of treatment for patients with HR-positive, HER2-negative disease who experience progression on CDK4/6 inhibition (9:40)
  • Current and future role of HER2-targeted therapy for HER2-low and HER2-ultralow mBC (19:46)
  • Selection and sequencing of therapy for patients with metastatic triple-negative breast cancer (29:53)
  • Emerging innovative interventions for the treatment of mBC (37:17)

CME information and select publications

  continue reading

1426 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide